2011
DOI: 10.3892/or.2011.1482
|View full text |Cite|
|
Sign up to set email alerts
|

Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation

Abstract: Abstract. microRNAs (miRs) are endogenous small noncoding RNAs that are aberrantly expressed in various carcinomas. miR-152 and miR-148a have not been comprehensively investigated in ovarian cancer. Thus, the aim of this study was to identify the role of miR-152 and miR-148a in epithelial ovarian cancer. Total RNA was extracted from tissues of 78 patients with epithelial ovarian cancer, 17 normal ovarian epithelium tissues and two ovarian cancer cell lines. Using quantitative real-time PCR (qRT-PCR) followed b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
47
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(48 citation statements)
references
References 36 publications
(42 reference statements)
1
47
0
Order By: Relevance
“…Plasma/serum miR-223 together with other miRNAs have been shown to be closely associated with the tumorigenesis and metastasis of gastric carcinoma (25), hepatocellular carcinoma or chronic hepatitis (26), sepsis (27), and lung cancer (28). Dysregulated miR-148a has been reported in ovarian cancer (29), liver injury (30), and gastric cancer (31). …”
Section: Resultsmentioning
confidence: 99%
“…Plasma/serum miR-223 together with other miRNAs have been shown to be closely associated with the tumorigenesis and metastasis of gastric carcinoma (25), hepatocellular carcinoma or chronic hepatitis (26), sepsis (27), and lung cancer (28). Dysregulated miR-148a has been reported in ovarian cancer (29), liver injury (30), and gastric cancer (31). …”
Section: Resultsmentioning
confidence: 99%
“…Of the miRNAs we assayed, miR-152 demonstrated the most significant reversal of expression, an effect consistent for both LNCaP and PC-3 cell lines. Previous reports regarding endometrial cancer [23], gastrointestinal cancer [27], and ovarian cancer [28, 29], and a report relating to PCa [30], published during the preparation of this manuscript, show that miR-152 levels are decreased in more advanced tumors. Analysis of patient data from the Taylor et al study, deposited in the NIH-sponsored Geo database, confirms that miR-152 expression is low in the more advanced primary tumors, with the lowest expression in metastatic samples.…”
Section: Discussionmentioning
confidence: 95%
“…The miR-148/152 family worked as a suppressor in many kinds of cancer [18-20]. Altered expression of miR-152 in ovarian is related to cell proliferation [21]. In breast cancer, overexpression of miR-152 repressed cell proliferation by targeting IGF-1R and IRS1 to suppress AKT and MAPK signaling pathways [20].…”
Section: Introductionmentioning
confidence: 99%